Thus, GLP-1 analogs, such as GLP-1 receptor agonists and DPP4 inhibitors, are being investigated to elucidate their potential in diabetes treatment, especially T1D [184]. The gene discussed is GLP1R; the disease is type 1 diabetes mellitus.